share_log

12 Health Care Stocks Moving In Friday's Pre-Market Session

Benzinga Real-time News ·  May 13, 2022 20:19

 

Gainers

  • Calithera Biosciences (NASDAQ:CALA) shares increased by 37.2% to $0.22 during Friday's pre-market session. The market value of their outstanding shares is at $24.7 million. The company's, Q1 earnings came out 3 days ago.
  • PolarityTE (NASDAQ:PTE) shares rose 35.15% to $0.2. The company's market cap stands at $17.7 million.
  • Celularity (NASDAQ:CELU) shares moved upwards by 25.47% to $7.24. The company's market cap stands at $997.0 million.
  • Molecular Partners (NASDAQ:MOLN) stock rose 19.47% to $7.26. The market value of their outstanding shares is at $234.4 million.
  • Baudax Bio (NASDAQ:BXRX) shares rose 19.45% to $1.19. The market value of their outstanding shares is at $7.6 million.
  • Inotiv (NASDAQ:NOTV) stock rose 17.05% to $14.0. The market value of their outstanding shares is at $356.4 million. As per the press release, Q2 earnings came out yesterday.

Losers

  • FIGS (NYSE:FIGS) stock decreased by 21.4% to $10.1 during Friday's pre-market session. The market value of their outstanding shares is at $1.6 billion. As per the press release, Q1 earnings came out yesterday.
  • Salarius Pharmaceuticals (NASDAQ:SLRX) stock declined by 18.92% to $0.18. The market value of their outstanding shares is at $10.0 million. As per the news, the Q1 earnings report came out yesterday.
  • Regulus Therapeutics (NASDAQ:RGLS) stock fell 18.16% to $0.2. The market value of their outstanding shares is at $29.3 million. As per the press release, Q1 earnings came out yesterday.
  • Ekso Bionics Holdings (NASDAQ:EKSO) shares decreased by 11.46% to $1.48. The company's market cap stands at $18.9 million.
  • Allakos (NASDAQ:ALLK) stock fell 7.72% to $2.87. The company's market cap stands at $157.2 million.
  • Brickell Biotech (NASDAQ:BBI) stock decreased by 7.21% to $0.19. The market value of their outstanding shares is at $22.9 million. As per the press release, Q1 earnings came out yesterday. See Also:

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment